Last update:

HIV & AIDS news

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

Most at-risk populations for HIV discussing the topic in negative, risky ways get the most social media attention

As the old saying goes, bad news travels fast. Research shows that saying holds true when it comes to young men discussing HIV on social media. An analysis of viral tweets from young men and adolescents, the most at-risk ...

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

Study examines novel drug candidate for treatment of neuroHIV

A recently published article in Experimental Biology and Medicine titled "LM11A-31, a modulator of p75 neurotrophin receptor, suppresses HIV-1 replication and inflammatory response in macrophages" highlights the potential ...

HIV & AIDS

Why male couples should think about HIV in their relationships

In a relationship there are myriad issues to manage. Who walks the dog? Does his mother like me? Whom are we supporting to win RuPaul's "Drag Race All Stars 2"? But there is one issue that can often be harder to manage – ...

HIV & AIDS

IPM's ring study results published

The International Partnership for Microbicides (IPM) announced today that The New England Journal of Medicine (NEJM) has published results from The Ring Study, a Phase III clinical trial of IPM's vaginal ring to prevent HIV. ...

HIV & AIDS

For one Egyptian with HIV, the stigma is too much to bear

In his bedroom, there's a drawer full of his medications—along with CDs of a popular Egyptian Muslim preacher. On the walls of the home are two paintings by his father. They've had a strained relationship. He opens an album ...

HIV & AIDS

HIV expert's studies yielding insights into diseases of aging

While AIDS originally was seen as an adaptive immune disease, the research of Alan Landay, PhD, has contributed to a view of it as a cell driven-inflammation linked to immunosenescence—the gradual deterioration of the immune ...

HIV & AIDS

S.Africa launches major new trial of AIDS vaccine

South Africa on Wednesday launched a major clinical trial of an experimental vaccine against the AIDS virus, which scientists hope could be the "final nail in the coffin" for the disease.

HIV & AIDS

HIV toll tops one million in Russia and keeps climbing

Russia's HIV infection rate is growing 10 percent a year and over one million Russian have been diagnosed with the disease in nearly three decades, the country's top AIDS expert said Tuesday.

HIV & AIDS

Almost half of HIV infections worldwide undetected: WHO

The World Health Organization warned on Tuesday that nearly half of all people with HIV around the globe do not know they are infected, and called for broader access to at-home testing kits.

HIV & AIDS

First new HIV vaccine efficacy study in seven years has begun

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves ...

HIV & AIDS

Genetically engineered T cells render HIV's harpoon powerless

When HIV attacks a T cell, it attaches itself to the cell's surface and launches a "harpoon" to create an opening to enter and infect the cells. To stop the invasion, researchers from the Penn Center for AIDS Research at ...